Reflow Medical, Inc. announced that the FDA has granted de novo clearance for the company’s Spur peripheral retrievable stent ...

The catheter features a stent directly coated with the photosensitiser Al-PcS4. A research team at South Korea’s Asan Medical ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

The global peripheral vascular stent market, valued at USD 4.26 billion in 2024 to reach USD 8.87 billion by 2034, at a CAGR of 7.60%. The self-expanding segment is the most lucrative segment with a ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

Reflow Medical received FDA de novo clearance for its Spur Peripheral Retrievable Stent System for infrapopliteal arterial ...

The stent had migrated into the liver and essentially turned into a stone,” explained Dr Dipak Bhangale, consultant ...

Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce the early commercial availability of its FDA-approved ROADSAVER™ Carotid Stent System. Indicated for use ...

Jean Chrétien missed King Charles delivering the speech from the throne Tuesday morning because he is recovering from heart ...

In 2023, the adoption of coronary stent in India stands at a valuation of USD 843.8 million. This surge is attributed to the demand for minimally invasive procedures to address the rising cases of ...